Skip to content
2000
Volume 7, Issue 6
  • ISSN: 1389-2002
  • E-ISSN: 1875-5453

Abstract

Despite its controversial past, thalidomide is currently under investigation for the treatment of several disease types, ranging from inflammatory conditions to cancer. The mechanism of action of thalidomide is complex and not yet fully understood, but there is some evidence to suggest that metabolism may play a role. Consequently, there has been a considerable effort to characterize the metabolism of thalidomide in recent years. Thalidomide undergoes biotransformation by non-enzymatic hydrolysis and enzyme-mediated hydroxylation to form a multitude of metabolites. Metabolite identification and reaction phenotyping studies have been performed and will be discussed in this review in addition to interspecies differences in thalidomide metabolism.

Loading

Article metrics loading...

/content/journals/cdm/10.2174/138920006778017777
2006-08-01
2025-09-01
Loading full text...

Full text loading...

/content/journals/cdm/10.2174/138920006778017777
Loading

  • Article Type:
    Research Article
Keyword(s): CYP2C19; Hydrolysis; hydroxylation; pharmacokinetics
This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error
Please enter a valid_number test